Glomerular injury in chronic myelomonocytic leukemia.

Among 825 cases of de novo myelodysplastic syndromes (MDS) diagnosed over a period of 13 years in our center, 4 had clinically significant glomerulopathy. All 4 fulfilled diagnostic criteria of chronic myelomonocytic leukemia (CMML), and could be classified in the low or intermediate risk groups according to two scoring systems. Presenting symptoms of renal involvement were edema in 3 cases and acute renal failure in the remaining patient. Three patients had the nephrotic syndrome. Renal biopsy (performed in 2 cases but considered as contraindicated in the other cases) showed AL amyloidosis on one case and extracapillary glomerulonephritis in the other case. The 4 patients were treated with V16 or hydroxyurea and two had renal improvement. Only one previous case of MDS associated with glomerulopathy has been reported before and also very probably had CMML. This, and the response of renal disease to chemotherapy in 2 of our patients suggests a possible relationship between the two disorders. More systematic investigation of glomerular function, in CMML, could possibly disclose a higher incidence of cases of glomerular injury in this type of MDS.

[1]  A. Duhamel,et al.  Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. , 1993, Leukemia.

[2]  J. Fillastre,et al.  Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. , 1992, Kidney international.

[3]  T. Hamblin,et al.  Immunologic abnormalities in myelodysplastic syndromes. , 1992, Hematology/oncology clinics of North America.

[4]  G. Mufti,et al.  A guide to risk assessment in the primary myelodysplastic syndrome. , 1992, Hematology/oncology clinics of North America.

[5]  S. Paydaş,et al.  A case with membranous glomerulonephritis and myelodysplastic syndrome. , 1992, Nephron.

[6]  R. Beuscart,et al.  Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  G. Mufti,et al.  Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival , 1988, British journal of haematology.

[8]  J. Buxbaum,et al.  Monoclonal Immunoglobulin Deposition Disease: Immunopathologic Aspects of Renal Involvement , 1988 .

[9]  G. Mufti,et al.  Immunological abnormalities in myelodysplastic syndromes I. SERUM IMMUNOGLOBULINS AND AUTOANTIBODIES , 1986, British journal of haematology.

[10]  Kyle Ra,et al.  Amyloidosis (AL). Clinical and laboratory features in 229 cases. , 1983 .

[11]  T. Phillips,et al.  Acute Myelomonocytic Leukemia Associated with Nephrotic Syndrome , 1983 .

[12]  J. Heironimus,et al.  Chronic myelogenous leukemia with nephrotic syndrome. , 1983, Archives of internal medicine.

[13]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[14]  W. Sizoo,et al.  Nephrotic syndrome in Hodgkin's disease. Report of five cases and review of the literature. , 1981, The Netherlands journal of medicine.

[15]  G. Lavie,et al.  Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes , 1978, The Journal of experimental medicine.

[16]  W. Pruzanski,et al.  Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia. , 1970, The Journal of clinical investigation.

[17]  E. Osserman,et al.  SERUM AND URINARY LYSOZYME (MURAMIDASE) IN MONOCYTIC AND MONOMYELOCYTIC LEUKEMIA , 1966, The Journal of experimental medicine.